NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that it has received approval for the distribution of Avenova from the Australian Government Department of Health and has been provided an Australian Register of Therapeutic Goods Certificate. “We are pleased to receive approval to market Avenova in Australia and are planning to engage a distributor